China Shineway Pharmaceutical Group Stock Forecast for 2023 - 2025 - 2030

Updated on 05/05/2024

Stock Rating
18
Price Target
HK$11.36
Consensus
Outperform
Upside
22.15%
Analysts
1
Stock Rating
18
Upside
22.15%
Analysts
1
Price Target
HK$11.36

China Shineway Pharmaceutical Group Stock Forecast and Price Target

The average price target of HK$11.36 for China Shineway Pharmaceutical Group's stock set by distinguished analysts in recent weeks would represent a potential upside of approximately 22.15% from the last closing price in May, 2024 if reached by the end of the year. This potential increase is based on a high estimate of HK$16.61 and a low estimate of HK$11.09. If you are interested in 2877 stock, it is important to also consider its competitors.

HK$11.36

22.15% Upside

Buy
Buy

China Shineway Pharmaceutical Group Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, China Shineway Pharmaceutical Group's Price has decreased from HK$5.23 to HK$0.00 – a 100.00% drop. Next year, analysts are expecting Fair Value to reach HK$10.69 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
HK$10.69
2025 Fair Value Forecast
HK$12.43
2026 Fair Value Forecast
HK$15.36
2027 Fair Value Forecast
HK$8.55
2028 Fair Value Forecast
HK$9.88
2029 Fair Value Forecast
HK$11.43
2030 Fair Value Forecast
HK$13.44
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600276 Stock Forecast Jiangsu Hengrui Medicine Buy 15
¥46.16 Buy/Sell ¥56.49 16.98%
T14 Stock Forecast Tianjin Pharmaceutical Da Ren ... Outperform 18
$34.99 Buy/Sell $1.70 30.89%
600436 Stock Forecast Zhangzhou Pientzehuang Pharmac... Outperform 18
¥237.24 Buy/Sell ¥302.86 19.10%
000538 Stock Forecast Yunnan Baiyao Group Co.,Ltd Outperform 18
¥57.25 Buy/Sell ¥65.39 11.79%
1093 Stock Forecast CSPC Pharmaceutical Group Buy 18
HK$6.76 Buy/Sell HK$9.50 37.57%

China Shineway Pharmaceutical Group Revenue Forecast for 2023 - 2025 - 2030

In the last three years, China Shineway Pharmaceutical Group's Revenue has grown from HK$2.66B to HK$4.52B – a 70.07% increase. Next year, analysts are expecting Revenue to reach HK$5.71B – an increase of 26.44%. Over the next seven years, the forecast is for Revenue to grow by 36.60%.

2024 Rev Forecast
HK$5.71B
2025 Rev Forecast
HK$6.73B
2026 Rev Forecast
HK$6.34B
2027 Rev Forecast
HK$5.71B
2028 Rev Forecast
HK$5.75B
2029 Rev Forecast
HK$6.06B
2030 Rev Forecast
HK$6.17B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
000999 Stock Forecast China Resources Sanjiu Medical... Buy 18
¥59.97 Buy/Sell ¥65.95 13.62%
600085 Stock Forecast Beijing Tongrentang Outperform 16
¥42.33 Buy/Sell ¥61.18 27.57%
600196 Stock Forecast Shanghai Fosun Pharmaceutical ... Outperform 16
¥23.67 Buy/Sell ¥33.57 20.83%

China Shineway Pharmaceutical Group Dividend per Share Forecast for 2023 - 2025 - 2030

In the last three years, China Shineway Pharmaceutical Group's Dividend per Share has grown by 31.25%, rising from HK$0.32 to HK$0.42. For next year, analysts predict Dividend per Share of HK$0.54, which would mean an increase of 28.57%. Over the next seven years, experts predict that China Shineway Pharmaceutical Group's Dividend per Share will grow at a rate of 56.97%.

2024 DPS Forecast
HK$0.54
2025 DPS Forecast
HK$0.62
2026 DPS Forecast
HK$0.75
2027 DPS Forecast
HK$0.62
2028 DPS Forecast
HK$0.60
2029 DPS Forecast
HK$0.61
2030 DPS Forecast
HK$0.66
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600079 Stock Forecast Humanwell Healthcare (Group) Buy 0
¥20.25 Buy/Sell ¥32.49 -100.00%
000513 Stock Forecast Livzon Pharmaceutical Group Outperform 18
¥36.98 Buy/Sell ¥39.23 11.41%
600518 Stock Forecast Kangmei Pharmaceutical - 6
¥1.99 Buy/Sell ¥25.97 -100.00%

China Shineway Pharmaceutical Group Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
HK$0.51B
2025 FCF Forecast
HK$0.75B
2026 FCF Forecast
HK$0.85B
2027 FCF Forecast
HK$0.85B
2028 FCF Forecast
HK$0.73B
2029 FCF Forecast
HK$0.74B
2030 FCF Forecast
HK$0.78B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
300146 Stock Forecast Byhealth Outperform 15
¥15.84 Buy/Sell ¥26.39 29.42%
002262 Stock Forecast Jiangsu Nhwa Pharmaceutical Co... Buy 18
¥25.01 Buy/Sell ¥31.34 23.95%
900904 Stock Forecast Shanghai Shenqi Pharmaceutical... - 13
$6.53 Buy/Sell $0.00 -100.00%

China Shineway Pharmaceutical Group EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, China Shineway Pharmaceutical Group's EBITDA has grown, rising from HK$628.76M to HK$1.14B – a growth of 80.67%. In the next year, analysts believe that EBITDA will reach HK$1.39B – an increase of 22.49%. For the next seven years, the forecast is for EBITDA to grow by 29.86%.

2024 EBITDA Forecast
HK$1.39B
2025 EBITDA Forecast
HK$1.60B
2026 EBITDA Forecast
HK$1.51B
2027 EBITDA Forecast
HK$1.38B
2028 EBITDA Forecast
HK$1.39B
2029 EBITDA Forecast
HK$1.46B
2030 EBITDA Forecast
HK$1.48B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600062 Stock Forecast China Resources Double-Crane P... Buy 16
¥21.77 Buy/Sell ¥26.00 18.24%
600380 Stock Forecast Joincare Pharmaceutical Group ... Buy 18
¥11.61 Buy/Sell ¥14.72 26.79%
002773 Stock Forecast Chengdu Kanghong Pharmaceutica... Buy 11
¥21.70 Buy/Sell ¥24.00 -100.00%

China Shineway Pharmaceutical Group EBIT Forecast for 2023 - 2025 - 2030

China Shineway Pharmaceutical Group's EBIT has grown In the last three years, rising from HK$429.31M to HK$970.10M – a growth of 125.97%. In the next year, analysts believe that EBIT will reach HK$1.24B – an increase of 27.94%. For the next seven years, experts predict that China Shineway Pharmaceutical Group's EBIT will grow at a rate of 54.60%.

2024 EBIT Forecast
HK$1.24B
2025 EBIT Forecast
HK$1.46B
2026 EBIT Forecast
HK$1.42B
2027 EBIT Forecast
HK$1.71B
2028 EBIT Forecast
HK$1.54B
2029 EBIT Forecast
HK$1.53B
2030 EBIT Forecast
HK$1.50B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600867 Stock Forecast Tonghua Dongbao Pharmaceutical Buy 18
¥10.09 Buy/Sell ¥14.25 45.49%
603858 Stock Forecast Shandong Buchang Pharmaceutica... - 18
¥16.85 Buy/Sell ¥0.00 -100.00%
000623 Stock Forecast Jilin Aodong Pharmaceutical Gr... Buy 16
¥15.28 Buy/Sell ¥0.00 48.36%

China Shineway Pharmaceutical Group EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, China Shineway Pharmaceutical Group's EPS has decreased from HK$0.66 to HK$0.00 – a 100.00% drop. Next year, analysts are expecting EPS to reach HK$1.35 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
HK$1.35
2025 EPS Forecast
HK$1.57
2026 EPS Forecast
HK$1.94
2027 EPS Forecast
HK$1.08
2028 EPS Forecast
HK$1.25
2029 EPS Forecast
HK$1.44
2030 EPS Forecast
HK$1.70
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
600422 Stock Forecast KPC Pharmaceuticals,Inc Buy 18
¥22.72 Buy/Sell ¥28.00 10.08%
000766 Stock Forecast Tonghua Golden-Horse Pharmaceu... - 11
¥17.16 Buy/Sell ¥33.00 -100.00%
002019 Stock Forecast Yifan Pharmaceutical Buy 16
¥13.24 Buy/Sell ¥16.42 43.50%